Clinical trial

Teneligliptin-Glimepiride DDI Study

NCT03009513

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-01-01

PhasePHASE1

Study timeline

Study start (actual)2017-01-01Date precision: month

Registry last updated2018-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Interventions

Teneligliptin+GlimepirideDRUG

Sponsors & collaborators

Handok Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03009513 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.